Jobs
View more job listings or post a job
Jazz Pharmaceuticals Senior Manager, Clinical Pharmacology
Nektar Therapeutics Research Associate III
Nektar Therapeutics Sr. Scientist, Bioanalytical
Genentech, Inc. Associate Scientist/Scientist, Drug Metabolism and Pharmacokinetics
Jubilant Discovery Services Senior Manager Business Development
Aimmune Therapeutics The Associate Director, Quality Control will be a key member of the analytical team and he/she will support activities associated with quality control activities of Aimmune’s APIs and drug products conducted at CTL/CMO.  
Precision for Medicine Senior Manager, Quality Assurance
Denali Therapeutics Bioanalytical Research Scientist, DMPK (SM/Biomarker)
Arena Pharmaceuticals The Principal Scientist will report to the Head of Analytical Sciences and will serve as the analytical lead in cross-functional product development tea
Genentech Associate Scientist/Scientist, Process Analytical Technology, Small Molecule Analytical Chemistry  
Post a job

Workshop

Small-Molecule Bioanalytical Method Validation & Regulated Bioanalysis: Fundamentals, the New FDA Guidance and Regulatory Trends


Speakers: Mark Rose, CHDI; David Humphries, Covance; Kristen Harman, ChemoCentryx; David Scharberg, Pharmaceutical Outsource Solutions; Steve Lowes, Q2 Solutions; Eric Woolf, Merck; Deqing Xiao, Gilead
Organizers: Thomas Tarnowski, Gilead; Kristen Harman, ChemoCentryx
Date: 2019-10-03
Time: 8:45-17:00 Pacific Time
Registration fee (USD): Regular: $195; Academic: $125; For unemployed or students: $30; For vendor-show rep: $35; For major-sponsor rep (incl lunch): $0
Location: SF Bay Area: Foster City Crowne Plaza
Major Sponsor: (3)Alturas Analytics; Eurofins Bioanalytical Services; WORLDWIDE CLINICAL TRIALS
Vendor show vendors registered to date: (17)AB Sciex; Absorption Systems; Adesis Inc.; BASi/Seventh Wave; BioDuro; Charles River Labs; ICON Clinical Research; Intertek; KCAS Bioanalytical & Biomarker Services; Lovelace Biomedical; Medpace; MicroConstants; Pacific BioLabs; Q2 Solutions; Quintara Discovery (QDI); SEKISUI XenoTech; WuXi AppTec
Registration: http://www.PBSS.org
Registration deadline:2019-10-01  (it will close sooner if the seating cap is reached)

About the Topic

Regulated bioanalysis (RBA) is required in the key parts of drug development that involve evaluations of drug safety, bioequivalence, and pharmacokinetics, and RBA data quality directly impacts the reliability of such assessments. RBA Method Validation requires compliance with various national method validation guidances, which will soon be superseded by harmonized guidance from the International Conference on Harmonisation (ICH).

To ensure successful assay applications and regulatory submissions, bioanalytical methods are extensively evaluated and validated for accuracy/precision, selectivity, specificity, sensitivity, recovery, and stability under various operational conditions. Data generated for validation and sample analyses and all documentation necessary for reconstructing the validation study and sample analyses, (e.g. experimental data, protocols, reports, staff training records, SOPs, etc.) needs to be maintained and available for data audit and inspection.

Presenters at this workshop are internationally recognized experts on RBA and regularly present at international bioanalytical conferences. The workshop includes a general introduction to regulated bioanalytical method development/validation and sample analysis, as well as presentations of things to consider when partnering with a bioanalytical contract research organization (CRO) to perform such work. Presenters will also cover how to comply with the guidances and regulations, and discuss recent topics relating to the newest FDA Bioanalytical Method Validation guidance and the draft ICH guidance.


Workshop Agenda:

8:45 - 9:00   Welcome - S.Miao & T.Tarnowski

9:00 - 10:30    1. Introduction to Regulated Bioanalysis - Mark Rose, CHDI Management, Inc.

10:30 - 10:40    Major Sponsor Presentation - Alturas

10:40 - 11:00    Break

11:00 - 11:30    2. Quality and Compliance for Regulated Bioanalysis - David Scharberg, Preclinical Outsourcing Services

11:30 - 12:00    3. Working successfully with Bioanalytical CROs (CRO Experience) - David Humphries, Covance

12:00 - 12:20   4. Working successfully with Bioanalytical CROs (Sponsor Experience) - Kristen Harman, ChemoCentryx

12:20 - 1:20   Lunch (Sponsored by Eurofins Bioanalytical Services)

1:20 - 2:15    5. Interpretation and Application of the 2018 FDA Guidance on Bioanalytical Method Validation - Steve Lowes, Q2 Solutions

2:15 - 2:25    Major Sponsor Presentation - Worldwide Clinical Trials

2:25 - 2:45    Break & Raffle

2:45 - 3:40    6. ICH M10 The Road to a Global Harmonized Bioanalytical Method Validation Guidance - Eric Woolf, Merck

3:40 – 4:20   7. Strategies for Determination of Small-Molecule Analytes in PBMCs - Deqing Xiao, Gilead

4:20 - 4:50  Q&A for Speaker Panel - All


2019-11-12, Antibody Drug Discovery and Development: Hit Generation, Engineering, Cell-line Development, IND enabling studies, and Biosimilars
2019-12-10, In Vitro Diagnostics (IVD), Companion Diagnostics (CDx) and Precision Medicine
2020-01-10, All about half-life: which one should I use? (tentative title)
2020-01-21, Considerations for Successful Clinical Development: Fundamentals and Best Practices for Clinical Trial Design, Biostatistics, and Data Management
2020-02-11, Development of Drug/Device Combinations
2020-02-24, MS Courses by Dr. Jack Henion: Advanced LC-MS/MS (Day1) & Interpretation of MS/MS CID Spectra (Day2)
2020-03-16, Clinical Trials Essentials: An Intensive One-Week Course (register for the full week or half day sessions)
2020-04-10, Biopolymer-based conjugation of therapeutic proteins and antibodies for improving drug properties (tentative title)
2020-05-12, Regulated Large Molecule Bioanalysis: Fundamentals, the New FDA Guidance and Beyond
2020-05-22, No More Undruggables: Unconventional Approaches for Drug Discovery and Design - prodrugs, PROTACS, fragment-based design, directed evolution and beyond
2020-06-23, Advances in Immuno-Oncology (A Joint Symposium by PBSS and BioScience Forum)
┬ęPharmaceutical & BioScience Society, International; Last Modified: 10/20/2019; Admin Logon
Ads (in random order)
Submit a Text Ad
($250 for 2 months)

Origin Bioanalytical Laboratory Sacramento-based CRO for bioanalytical method development, validation, and consulting of LC-MS/MS analysis, specializing in ocular matrices
BIOTECH WEEK BOSTON - Sept. 9-12 Access over 5,000 of the most innovative scientific minds & business leaders in Boston and around the world. Learn More.
XCELERATE at Biotech Week Boston Driving the Future of the Life Science Industry. Sept. 11 at BCEC. Learn more.
UC Davis UC Davis LC/MS Confirmation Supervisor (Lab Rsch Supv 2) Apply Online: http://50.73.55.13/counter.php?id=165482 UC Davis is an AA/EOE
Adesis Inc. Adesis provides expertise in custom synthesis, process dev, R&D, and specialty mfg. to pharma, chemical, biomaterials, and catalysts companies
Alturas Analytics, Inc. Expert GLP & non-GLP LC-MS/MS & GC-MS/MS bioanalytical quantitation services of small & large molecules in any matrix. Discovery through phase IV.
Submit a Text Ad